Thursday, May 2, 2013

Vol. 19, No. 9

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 9 May 2, 2013
(The next issue will be on May 15, 2013)
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings:
http://tf7.org/meetings.htm
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1toD9bFe4gC47nQLD3PzJGn/

Adam SS, Hoppe C (2013) Potential role for statins in sickle cell disease. Pediatr Blood Cancer 60:550-557.
http://www.ncbi.nlm.nih.gov/pubmed/23281161

Amin H, Mohsin S, Aslam M, Hussain S, Saeed T, Ullah MI, Sami W (2012) Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population. Blood Coagul Fibrinolysis 23:745-750.
http://www.ncbi.nlm.nih.gov/pubmed/23135380

Anglin CO, Spence JS, Warner MA, Paliotta C, Harper C, Moore C, . . . Diaz-Arrastia R (2013) Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. J Neurosurg 118:676-686.
http://www.ncbi.nlm.nih.gov/pubmed/23259827

Arderiu G, Pena E, Aledo R, Espinosa S, Badimon L (2012) Ets-1 transcription is required in tissue factor driven microvessel formation and stabilization. Angiogenesis 15:657-669.
http://www.ncbi.nlm.nih.gov/pubmed/22869003

Baumann Kreuziger LM, Morton CT, Reding MT (2013) Is prophylaxis required for delivery in women with factor VII deficiency? Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23607277

Beleva E, Grudeva-Popova J (2013) From Virchow's triad to metastasis: circulating hemostatic factors as predictors of risk for metastasis in solid tumors. J BUON 18:25-33.
http://www.ncbi.nlm.nih.gov/pubmed/23613385

Byrne M, Zumberg M (2012) Intentional low-molecular-weight heparin overdose: a case report and review. Blood Coagul Fibrinolysis 23:772-774.
http://www.ncbi.nlm.nih.gov/pubmed/23135382

Chen C, Mei H, Shi W, Deng J, Zhang B, Guo T, . . . Hu Y (2013) EGFP-EGF1-Conjugated PLGA Nanoparticles for Targeted Delivery of siRNA into Injured Brain Microvascular Endothelial Cells for Efficient RNA Interference. PLoS One 8:e60860.
http://www.ncbi.nlm.nih.gov/pubmed/23593330

Chuansumrit A, Sirachainan N, Panuwannakorn M, Wongwerawattanakoon P, Kadegasem P, Choeyprasert W, Sasanakul W (2013) Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors. Haemophilia 19:e182-183.
http://www.ncbi.nlm.nih.gov/pubmed/23600908

Eisenreich A, Zakrzewicz A, Huber K, Thierbach H, Pepke W, Goldin-Lang P, . . . Rauch U (2013) Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells. Oncol Rep.
http://www.ncbi.nlm.nih.gov/pubmed/23604472

Escobar MA (2013) Advances in the treatment of inherited coagulation disorders. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23600951

Ferreira J, Delossantos M (2013) The Clinical Use of Prothrombin Complex Concentrate. J Emerg Med.
http://www.ncbi.nlm.nih.gov/pubmed/23602147

Franz C, Boing AN, Hau CM, Montag M, Strowitzki T, Nieuwland R, Toth B (2013) Procoagulant tissue factor-exposing vesicles in human seminal fluid. J Reprod Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/23578769

Geenen IL, Post MJ, Molin DG, Schurink GW, Maessen JG, van Oerle R, . . . Spronk HM (2012) Coagulation on endothelial cells: the underexposed part of Virchow's Triad. Thromb Haemost 108:863-871.
http://www.ncbi.nlm.nih.gov/pubmed/22955519

Geng Y, Verhamme IM, Sun MF, Bajaj SP, Emsley J, Gailani D (2013) Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23617568

Girolami A, de Marinis GB, Bertozzi I, Peroni E, Tasinato V, Lombardi A (2013) Discrepant ratios of arterial vs venous thrombosis in hemophilias a and b as compared with fvii deficiency. Eur J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/23621110

Girolami A, de Marinis GB, Bonamigo E, Lombardi AM (2012) Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias. Hematology 17:346-349.
http://www.ncbi.nlm.nih.gov/pubmed/22980722

Girolami A, Scarparo P, Bonamigo E, Treleani M, Lombardi AM (2012) Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin. Hematology 17:350-354.
http://www.ncbi.nlm.nih.gov/pubmed/23168073

Girolami A, Treleani M, Scarparo P, Bonamigo E, Lombardi AM (2012) Considerations on a tentative classification of FVII deficiency suited for practical clinical purposes. Clin Appl Thromb Hemost 18:654-657.
http://www.ncbi.nlm.nih.gov/pubmed/22411998

Godier A, Samama CM, Susen S (2013) [Management of massive bleeding in 2013: Seven questions and answers.]. Transfus Clin Biol.
http://www.ncbi.nlm.nih.gov/pubmed/23587620

Gracia J, Prieto I (2011) Recombinant activated factor VII as treatment for uncontrolled mucosal haemorrhage. BMJ Case Rep 2011.
http://www.ncbi.nlm.nih.gov/pubmed/22693200

Hu L, Xia L, Zhou H, Wu B, Mu Y, Wu Y, Yan J (2013) TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCalpha and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620. Tumour Biol.
http://www.ncbi.nlm.nih.gov/pubmed/23616010

Huang FY, Mei WL, Tan GH, Dai HF, Li YN, Guo JL, . . . Lin YY (2013) Cytochalasin D promotes pulmonary metastasis of B16 melanoma through expression of tissue factor. Oncol Rep.
http://www.ncbi.nlm.nih.gov/pubmed/23615686

Kaku S, Suzuki M, Saitoh M, Funatsu T, Uemura T, Suzuki KI, . . . Kawasaki T (2013) Darexaban: Anticoagulant effects in mice and human plasma in vitro, antithrombotic effects in thrombosis and bleeding
models in mice and effects of anti-inhibitor coagulant complex and recombinant factor VIIa. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23591155

Kothari H, Pendurthi UR, Rao LV (2013) Analysis of tissue factor expression in various cell model systems: cryptic vs. active. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23621622

Landsem A, Nielsen EW, Fure H, Christiansen D, Ludviksen JK, Lambris JD, . . . Brekke OL (2013) C1-inhibitor efficiently inhibits E. coli-induced tissue factor mRNA upregulation, monocyte tissue factor expression and coagulation activation in human whole blood. Clin Exp Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/23607270

Leers MP, Keuren JF, Frissen ME, Huts M, Kragten JA, Jie KS (2013) The pro- and anticoagulant role of blood-borne phagocytes in patients with acute coronary syndrome. Thromb Haemost 110.
http://www.ncbi.nlm.nih.gov/pubmed/23595567

Ljung R, Karim FA, Saxena K, Suzuki T, Arkhammar P, Rosholm A, Giangrande P (2013) 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23578227

Lv F, Xu X, Zhang S, Wang L, Wang N, He B, Wang J (2012) Repeated abortion affects subsequent pregnancy outcomes in BALB/c mice. PLoS One 7:e48384.
http://www.ncbi.nlm.nih.gov/pubmed/23119001

Ma Q, Nie X, Yu M, Wang Z, Yang S, Jia D, Zhou Y (2012) Rapamycin regulates the expression and activity of Kruppel-like transcription factor 2 in human umbilical vein endothelial cells. PLoS One 7:e43315.
http://www.ncbi.nlm.nih.gov/pubmed/22937032

Magnus N, Gerges N, Jabado N, Rak J (2013) Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23582031

Maugeri N, Franchini S, Campana L, Baldini M, Ramirez GA, Sabbadini MG, . . . Manfredi AA (2012) Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity 45:584-587.
http://www.ncbi.nlm.nih.gov/pubmed/22928592

Mei H, Hu Y, Wang H, Shi W, Deng J, Guo T (2010) Binding of EGF1 domain peptide in coagulation factor VII with tissue factor and its implications for the triggering of coagulation. J Huazhong Univ Sci Technolog Med Sci 30:42-47.
http://www.ncbi.nlm.nih.gov/pubmed/20155454

Morel O, Jesel L, Abbas M, Morel N (2013) Prothrombotic Changes in Diabetes Mellitus. Semin Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/23629823

O'Leary H, Ou X, Broxmeyer HE (2013) The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation. Curr Opin Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/23594692

Osterud B, Olsen JO (2013) Human platelets do not express tissue factor. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23623171

Otsuka T (2013) [Mechanism and risk factors of cardiogenic thromboembolism in patients with atrial fibrillation]. Nihon Rinsho 71:36-40.
http://www.ncbi.nlm.nih.gov/pubmed/23631169

Pan J, Ma D, Sun F, Liang W, Liu R, Shen W, . . . Shi H (2013) Over-expression of TFPI-2 promotes atherosclerotic plaque stability by inhibiting MMPs in apoE mice. Int J Cardiol.
http://www.ncbi.nlm.nih.gov/pubmed/23608390

Robbins A, Fong J, Hall W, Ditch K, Rolfe S, Miller M (2013) Comparison of a Low, Fixed Dose and a High, Weight-Based Dose of Recombinant Factor VIIa in the Treatment of Warfarin-Associated Intracranial Hemorrhage. Neurocrit Care.
http://www.ncbi.nlm.nih.gov/pubmed/23595666

Roedel EK, Schwarz E, Kanse SM (2013) The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2). J Biol Chem 288:7193-7203.
http://www.ncbi.nlm.nih.gov/pubmed/23341458

Salcioglu Z, Akcay A, Sen HS, Aydogan G, Akici F, Tugcu D, . . . Baslar Z (2012) Factor VII deficiency: a single-center experience. Clin Appl Thromb Hemost 18:588-593.
http://www.ncbi.nlm.nih.gov/pubmed/22327826

Song HB, Park KD, Kim JH, Kim DH, Yu YS, Kim JH (2012) Tissue factor regulates tumor angiogenesis of retinoblastoma via the extracellular signal-regulated kinase pathway. Oncol Rep 28:2057-2062.
http://www.ncbi.nlm.nih.gov/pubmed/23007470

Stephenson K, Neuenschwander PF, Kurdowska AK (2013) The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women. Int J Pharm Compd 17:74-85.
http://www.ncbi.nlm.nih.gov/pubmed/23627249

Syburra T, Siciliano RD, Hofer C, Genoni M (2013) Mitral valve surgery in severe congenital factor VII deficiency. Hematology.
http://www.ncbi.nlm.nih.gov/pubmed/23621922

Tormoen GW, Khader A, Gruber A, McCarty OJ (2013) Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor. Phys Biol 10:036003.
http://www.ncbi.nlm.nih.gov/pubmed/23585459

Winckers K, Ten Cate H, Hackeng TM (2013) The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis. Blood Rev.
http://www.ncbi.nlm.nih.gov/pubmed/23631910

Zantek ND, Hsu P, Refaai MA, Ledford-Kraemer M, Meijer P, Van Cott EM (2013) Factor VII assay performance: an analysis of the North American Specialized Coagulation Laboratory Association proficiency testing results. Int J Lab Hematol 35:314-321.
http://www.ncbi.nlm.nih.gov/pubmed/23590660
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________